Our Patented Solution to Painful Shots is a $2.2B Market Opportunity

9 out of 10 dentists say they want a less-painful, faster-acting anesthetic.3 We invented one. Our patented solution could be worth $22 million in revenue for every 1% of market share we get.6 Now we need your help to finish FDA trials and start taking the pain out of visiting the dentist.

Get in for  $4/Share
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
View Offering Circular
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
PROBLEM

Taking the Sting Out of Visiting the Dentist

The numbing shots dentists use are filled with an acidic preservative. That acid causes the shot to sting as it's injected. Nearly 60% of dental patients say the numbing shot is the worst part of going to the dentist. And what dentist wants to cause a patient pain? No wonder 9 out of 10 dentists want to give a less painful shot too.

of patients believe the injection is the worst part of the dental experience¹
of patients want a less-painful dental injection²
of dentists want an improved dental anesthetic³

Current Dental Injections⁴

Painful injection
Long wait time
20% avg. failure rate
Time & money wasted

Acid is the Culprit

Acid, added to preserve local anesthetics, is irritating to gum tissue and must be slowly neutralized by the body to activate the drug.  This causes pain and delays nerve blockade onset.

Our Unparalleled Solution

Our patented Libracaine cartridge gives dentists a buffered anesthetic that fits inside a standard dental syringe for the first time in medical history. The novel design combines a bicarbonate buffering agent with the acidic anesthetic as the syringe is pressed, neutralizing the pain-causing acid as it’s injected.

Buffered vs. Unbuffered Anesthetics⁵

Less painful
Faster-acting
More reliable
Increased efficiency
Marketing advantage

Invest in a Better Dental Injection

Balanced Pharma is pioneering the movement toward faster-acting, less painful dental injections.

Become an investor today!

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Dentists Are Ready for Libracaine8

90%
Would prefer their current anesthetic to be faster acting, less painful, or more relible.
87%
Are likely to adopt Libracaine.
84%
Would change suppliers if necessary to purchase Libracaine.
Simple and consistent buffering in a standard dental cartridge will be a game-changer.
- Jason Goodchild, DMD. Dr. Goodchild is Vice President of Clinical Affairs at Premier Dental Products and holds academic appointments at the University of Pennsylvania School of Dental Medicine, Rutgers School of Dental Medicine, and Creighton University School of Dentistry. He has authored more than 50 research papers on the subject of dental pain management.
MARKET

Large Market Opportunity

$22 Million In Revenue

We estimate $22 million in revenue for each 1% of the dental market share.

744 Million Units/Year

Current usage in target markets is 744 million cartridges/year, and our average price is $3/cartridge.

Industry Expansion

We believe we can adapt our technology to dermatology, plastic surgery, emergency medicine, interventional radiology, and podiatry.9
$2.2B
Market⁶
(744M cartridges/year x $3/cartridge)

Let’s Bring This Novel Product to Market

Our novel anesthetic cartridge received patent protection in April 2022. Currently, we’re making our way through the FDA approval process and are looking for investors to help us cross the finish line. You have the unique opportunity to help get this solution out of the lab and into dentists’ hands by investing today.

Invest In Balanced Pharma
Get in for $4/Share

Invest in a Better Dental Injection

Balanced Pharma is pioneering the movement toward faster-acting, less painful dental injections.

Become an investor today!

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Story

Created by Dentists, for Dentists: Our Founder’s Story

After 30 years as a practicing dentist, Dr. Scott Keadle knew anesthetics needed improvement:

  • Dental patients suffer nearly 2 billion painful and time-consuming injections each year.6
  • The acid preservative in anesthetics causes pain and delays the anesthetic effect.
  • Dentists have sought a cost-effective way to neutralize (“buffer”) the acid for decades, with no success.

Patented technology that neutralizes the acid in dental anesthetics:

Dedicated to solving the problem, Dr. Keadle invented a dual-chambered dental cartridge that provides an acid-free (“buffered”) version of the most common dental anesthetics, using a standard syringe and protocol.

Teaming up with dentists to bring a long-sought anesthetic to market:

Dr. Keadle presented his technology to dental colleagues who invested over $1 million to help found Balanced Pharma, Incorporated (BPI). Now a team of industry experts are building upon the patented technology he created to bring the first-ever acid-free (“buffered”) dental anesthetic to market.

The Team

J. Scott Keadle

Chairman and CEO
    Founder & CEO at Balanced Pharma, 30+ years as a dentist, practice owner & business executive

    John Selig

    Board Director
      Managing Partner at WaveEdge Capital, 25+ years in life science investment banking and M&A practice

      Beth Lindsey

      New Product Launch,
      Strategic Sourcing, Contracts
        Partner at Verta Life Sciences, 35+ years in pharma and medical device management

        Ian Smart

        Product Development
          Partner at Verta Life Sciences, 25+ years in pharma & medical device project management

          Nick Davies

          Manufacturing
            Partner at Verta Life Sciences, 30+ years and $5B+ in global product and supply chain management

            Cory McClelland

            Chief Financial Officer
              CFO at Balanced Pharma, 35+ years as CFO, financial and operational executive, and financial consultant

              Jason Suggs

              Chief Communications Officer
                CEO at Orange Reef, 20+ years in brand strategy, communications, and technology

                Brooks Thode

                Cartridge Manufacturing
                  Business Development Director at Aenova, 19+ years in pharma manufacturing and business development

                  Andrew Lee

                  Pharmacology Intern
                    B.S., Neuroscience, Michigan State University; PharmD candidate

                    Sara Hanks, Esq.

                    Securities Counsel
                      CEO, CrowdCheck Law Firm

                      Byron Kirkland, Esq.

                      Managing Partner, Smith Anderson Law Firm
                        Managing Partner, Smith Anderson Law Firm

                        Greg Carlin, Esq.

                        Intellectual Property Counsel
                          Partner, Meunier, Carlin, & Curfman Law Firm

                          Scientific Advisory Board

                          Jason Goodchild, DMD

                          Scientific Advisor
                            VP of Clinical Affairs at Premier Dental Products, academic appointments at Creighton University School of Dentistry, Rutgers School of Dental Medicine, and University of Pennsylvania School of Dental Medicine, numerous publications on dental anesthetics and dental anesthetic buffering.

                            Mark Donaldson, Pharm.D.

                            Scientific Advisor
                              Associate Principal at Vizient Pharmacy Advisory Solutions, 17+ years as a recognized expert in dental pharmacology, He holds academic appointments at the University of Montana and the Oregon Health & Sciences University and serves on the editorial board of the Journal of the American Dental Association.  

                              John B. Roberson, DMD

                              Scientific Advisor
                                Oral & Maxillofacial Surgeon; CEO and Co-Founder of AAFDO (Accreditation Association For Dental Offices); CEO and Co-founder. of the Institute of Medical Emergency Preparedness; author and lecturer; selected as a CE Leader for Dentistry Today for 10 consecutive years.

                                Jay B. Reznick, D.M.D., M.D.

                                Scientific Advisor
                                  Director of the Southern California Center for Oral and Facial Surgery in Tarzana, California; Diplomate
                                  of the American Board of Oral and Maxillofacial Surgery; the first specialist in the U.S. to integrate CBCT and CAD/CAM in his practice; has been published extensively in dental and medical literature

                                  Enter Your Email To Gain Access To The Investment Opportunity

                                  Thank you! Your submission has been received!
                                  Oops! Something went wrong while submitting the form.

                                  Leaving already?

                                  Join the Balanced Pharma mailing list to receive live investor updates!

                                  Thank you! Your submission has been received!
                                  Oops! Something went wrong while submitting the form.